Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 1

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Other hematologic neoplasm 1

Conditions

Colorectal Neoplasms 2Weight Loss 1Pancreatic Neoplasms 1Disease 1Cachexia 1Adenocarcinoma 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × bermekimab × Gastrointestinal × Clear all
NCT01767857 2021-06-29

XCITE

Janssen Research & Development, LLC

Phase 3 Terminated
643 enrolled 16 charts
Gastrointestinal

Colorectal Neoplasms

NCT02138422 2021-03-01

A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer

Janssen Research & Development, LLC

Phase 3 Completed
276 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03207724 2020-12-30

OnFX

Cedars-Sinai Medical Center

Phase 1 Completed
16 enrolled
Gastrointestinal

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡